PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | |heart failure |
| Sentences | 141 |
| PubMedID- 26065643 | The value of abs in patients after acute myocardial infarction (ami) without heart failure is also currently determined in a recent clinical trial.2 this trial found that early ab in patients presenting for primary percutaneous coronary intervention for acute st-elevation mi is clearly associated with a reduction in the incidence of life-threatening ventricular arrhythmia. |
| PubMedID- 24339455 | Chronic heart failure, as a result of acute myocardial infarction, is a leading cause of death worldwide. |
| PubMedID- 26110104 | The patient was diagnosed with acute decompensated heart failure due to acute myocardial infarction.figure 3axial contrast-enhanced computed tomography at the level of the heart (a), left portal vein of the liver (b), and pancreatic body (c). |
| PubMedID- 23196683 | The ephesus study showed that eplerenone can reduce mortality in the short and long term and the rate of new hospitalizations after a myocardial infarction complicated by heart failure. |
| PubMedID- 25522363 | As heart failure due to myocardial infarction remains a leading cause of morbidity worldwide, cell-based cardiac regenerative therapy using cardiac progenitor cells (cpcs) could provide a potential treatment for the repair of injured myocardium. |
| PubMedID- 26005421 | The purpose of the allstar study (allogeneic heart stem cells to achieve myocardial regeneration) is to investigate the safety and efficacy of the treatment in decreasing infarct size, with the primary efficacy endpoint being the relative percentage improvement in infarct size as assessed using magnetic resonance imaging at 6 and 12 months post-infusion (allogeneic heart stem cells to achieve myocardial regeneration (allstar) (nct01458405)2. more recently, a phase i/ii randomized, double-blind, placebo controlled clinical trial was proposed by a european study group initiative (care-mi) to investigate the therapeutic role of allogeneic cscs in patients with congestive heart failure due to myocardial infarction (crisostomo et al., 2015). |
| PubMedID- 25840550 | Other studies report the predictive value of cardiopulmonary exercise testing in heart failure patients with previous myocardial infarction [32]. |
| PubMedID- 22163222 | This interpretation is in agreement with experimental evidence indicating a pro-arrhythmic effect of sympatho-excitation (lown and verrier, 1976) and also with the findings that a reduction of these parameters is associated with an increased cardiac mortality in almost all clinical conditions characterized by an autonomic imbalance, e.g., after myocardial infarction, in patients with heart failure, hypertension, or diabetes (kleiger et al., 1987; malik and camm, 1995; task force of the european society of cardiology and the north american society of pacing and electrophysiology, 1996; fauchier et al., 1997; nolan et al., 1999; rashba et al., 2006). |
| PubMedID- 22293888 | [41] recently observed that ms predicted congestive heart failure independent of interim myocardial infarction in elderly finns [41]. |
| PubMedID- 24045768 | Objective: previous studies in post-myocardial infarction patients with heart failure have documented that high anxiety levels are associated with increased mortality. |
| PubMedID- 20081109 | Glp-1 improves left ventricular ejection fraction (lvef) in dogs with heart failure (hf) and in patients with acute myocardial infarction. |
| PubMedID- 24464979 | Methods and results: we studied 27 610 patients from four randomized trials of acute myocardial infarction complicated by heart failure and/or lv dysfunction (lvef |
| PubMedID- 23960370 | However, the causes of death from ad have been determined to be heart failure due to myocardial infarction, aortic regurgitation or cardiac tamponade, cerebral infarction, multiple organ failure due to ischemia or circulatory insufficiency, or bleeding due to rupture of the aorta. |
| PubMedID- 22357361 | Additional efforts should therefore be made to encourage the prescription of recommended medications in acute myocardial infarction patients with congestive heart failure. |
| PubMedID- 24751462 | Efficacy of intravenous levosimendan in patients with heart failure complicated by acute myocardial infarction. |
| PubMedID- 25217654 | We aimed to establish an ischemic heart failure (hf) model with a larger myocardial infarction (mi) relative to previous studies, and characterize the functional and structural features of this model. |
| PubMedID- 20193835 | Acute myocardial infarction complicated by heart failure increased, and cardiogenic shock decreased. |
| PubMedID- 25885579 | He was found to have a non-st segment elevation myocardial infarction with decompensated heart failure with ejection fraction of 24%, as well as acute kidney injury secondary to cardiorenal syndrome. |
| PubMedID- 26225841 | Enhanced nitric oxide bioavailability in coronary arteries prevents the onset of heart failure in rats with myocardial infarction. |
| PubMedID- 26070595 | Our aim was to correlate urine ngal with markers of in-hospital heart failure in patients with acute st-elevation myocardial infarction (stemi). |
| PubMedID- 21545710 | Background: progressive remodeling of the left ventricle (lv) following myocardial infarction (mi) can lead to congestive heart failure, but the underlying initiation factors remain poorly defined. |
| PubMedID- 26209495 | Results: patients having cuf were more likely to have diabetes, vascular disease, chronic obstructive pulmonary disease, congestive heart failure, history of a myocardial infarction, or an intraaortic balloon pump (p < 0.05). |
| PubMedID- 25442431 | Unlike some organs, the heart has a limited ability to regenerate, and dysfunction resulting from significant cardiomyocyte loss under pathophysiological conditions, such as myocardial infarction (mi), can lead to heart failure. |
| PubMedID- 21122202 | [the use of recombinant human b-type natriuretic peptide for the protection of cardiac and renal functions in heart failure patients with acute anterior myocardial infarction in peri-operative period of primary percutaneous coronary intervention]. |
| PubMedID- 22873828 | Inclusion of a supervised outpatient cardiac rehabilitation program is clearly more cost-effective than not including cardiac rehabilitation program (“usual or standard care”) into the overall management of patients after myocardial infarction or those with chronic heart failure. |
| PubMedID- 24876877 | A new born infant whose mother ingested an herbal medication, blue cohosh, to promote uterine contractions presented with acute myocardial infarction associated with profound congestive heart failure and shock [7]. |
| PubMedID- 20407137 | After suffering a small myocardial infarction (stemi) complicated by mild congestive heart failure, he reported back to his family doctor for post-hospital review. |
| PubMedID- 24112470 | The results were essentially unchanged when subjects with incident myocardial infarction or hospitalizations because of heart failure were censored from the analysis (hr 1.30, 95% ci 1.13-1.51; p for trend = 0.001). |
| PubMedID- 24753702 | Trends in hospitalized acute myocardial infarction patients with heart failure in korea at 1998 and 2008. |
| PubMedID- 23840832 | The most compelling evidence for the cardiovascular benefits of n-3 pufas comes from studies of primary and especially secondary prevention of coronary heart disease, and most recently, in post-myocardial infarction patients with heart failure. |
| PubMedID- 24826250 | Here we report a surgical treatment experience in an 81-year-old patient who suffered from heart failure due to acute myocardial infarction and went on to be diagnosed with valvular disease and vsd. |
| PubMedID- 26424212 | Serum uric acid is associated with mortality and heart failure hospitalizations in patients with complicated myocardial infarction: findings from the high-risk myocardial infarction database initiative. |
| PubMedID- 21749886 | Trials in patients after myocardial infarction and with chronic heart failure have seen limited and mixed success, probably because of the various cell types and methods used. |
| PubMedID- 22106414 | Aims: myocardial infarction leads to heart failure and death. |
| PubMedID- 21375762 | The expectation that bp agents have beneficial effects independent of the blood pressure-lowering one (pleiotropic effects) is still deep-rooted in physician's minds, but it has been repeatedly dismissed by independent clinical trials and by a large meta-analysis [7] the efficacy of beta-blockers in patients recovering from a myocardial infarction and in patients with heart failure, of ace inhibitors in patients with heart failure, coronary heart disease, other evidences of atherosclerotic vascular disease or diabetes, and patients recovered from a stroke (with a diuretic) can be almost fully explained by the blood pressure-lowering effect [22]. |
| PubMedID- 24453093 | This article refers to 'impact of aspirin and statins on longterm survival in patients with acute myocardial infarction complicated by heart failure: an analysis in 1746 patients' by c. |
| PubMedID- 25722046 | Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction. |
| PubMedID- 20730062 | A meta-analysis of all randomized trials showed that amiodarone reduced total mortality by 10 to 19%.30 the risk reduction was similar in primary prevention after myocardial infarction or in patients with congestive heart failure (chf), and in secondary prevention after cardiac arrest.30 in a pooled database from 2 similar randomized clinical trials (the european amiodarone myocardial infarction trial (emiat) and the canadian amiodarone myocardial infarction trial (camiat)), that evaluated use of amiodarone in primary prevention in patients recovering from myocardial infarction, cardiac death and arrhythmic death or resuscitated cardiac arrest, were significantly lower in patients receiving amiodarone, compared to placebo (p = 0.05 and 0.03, respectively), if they were also receiving beta-blockers.31 there appeared to be no benefit of amiodarone over placebo in patients not receiving beta-blockers. |
| PubMedID- 23553674 | In order to examine the reversibility of heart failure due to myocardial infarction (mi) by beta-adrenoceptor blockade, 12 weeks infarcted rats were treated with or without metoprolol (50 mg/kg/day) for 8 weeks. |
| PubMedID- 22872593 | Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the ephesus trial. |
| PubMedID- 25679083 | These individuals are more likely to be older, female, obese, diabetic, hyperlipidemic, hypertensive, and to have coronary artery disease, but less likely to have had a myocardial infarction.60,61 ahf with underlying heart failure with reduced ejection fraction is often associated with some degree of systolic pump failure; in cases of heart failure with a preserved ejection fraction, a stiff noncompliant ventricle along with noncardiac pathophysiologic factors predominate. |
| PubMedID- 21199333 | Cardiovascular disease (cvd), especially myocardial infarction (mi) with resultant congestive heart failure (chf), is a leading cause of mortality and morbidity worldwide [1]. |
| PubMedID- 23046599 | Background: left ventricular (lv) remodeling takes place after acute myocardial infarction (mi), potentially leading to overt heart failure (hf). |
| PubMedID- 23028218 | Cardiopathy such as myocardial infarction, a potential cause of heart failure, has become one of the leading causes of morbidity and mortality.1 the cardiomyocytes die rapidly without sufficient blood supply when myocardial infarction occurs. |
| PubMedID- 22095736 | The therapeutic challenge is considerable: a typical large myocardial infarction that leads to heart failure will kill around 1 billion cardiac myocytes (laflamme & murry, 2005), roughly a quarter of the heart's myocytes (fig 4). |
| PubMedID- 20874717 | (a–c) toluidine blue-positive mast cells are shown (as indicated by black arrowheads) in the endocardium (upper panels) of sham and post-myocardial infarction (mi) rats with heart failure treated with tat or βiiv5-3. |
| PubMedID- 21756327 | myocardial infarction (mi) often leads to heart failure (hf), which makes mi a leading source of morbidity and hospitalizations [1]. |
| PubMedID- 23827578 | myocardial infarction, a main cause of heart failure, leads to loss of cardiac tissue impairment of left ventricular function. |
| PubMedID- 24282249 | Risks associated with exercise training and testing are sudden cardiac death associated with ventricular arrhythmias, acute myocardial infarction, and in patients with chronic heart failure, pulmonary oedema and deterioration in left ventricular function.73 the last is only found in one study from 198874 and has not subsequently been demonstrated in larger studies.7576 in a recent french study of more than 25 000 patients with ischaemic heart disease, one-third with chronic heart failure found the risk of cardiac complications at 1:8500 exercise testing and 1:50 000 patient exercise hours.77 increasing exercise intensity and age are risk indicators. |
| PubMedID- 21742099 | Growth differentiation factor 15 (gdf-15) has an established role as a marker for risk stratification and mortality both in patients after acute myocardial infarction and in patients with heart failure. |